Patent details
EP3639811 Title: NOVEL PHARMACEUTICAL COMPOSITION COMPRISING PARTICLES COMPRISING A COMPLEX OF A DOUBLE-STRANDED POLYRIBONUCLEOTIDE AND A POLYALKYLENEIMINE
Basic Information
- Publication number:
- EP3639811
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP191922301
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- NOVEL PHARMACEUTICAL COMPOSITION COMPRISING PARTICLES COMPRISING A COMPLEX OF A DOUBLE-STRANDED POLYRIBONUCLEOTIDE AND A POLYALKYLENEIMINE
- French Title of Invention:
- NOUVELLE COMPOSITION PHARMACEUTIQUE COMPRENANT DES PARTICULES COMPRENANT UN COMPLEXE D'UN POLYRIBONUCLÉOTIDE DOUBLE BRIN ET UNE POLYALKYLÈNEIMINE
- German Title of Invention:
- NEUARTIGE PHARMAZEUTISCHE ZUSAMMENSETZUNG UMFASSEND PARTIKEL UMFASSEND EINEN KOMPLEX EINES DOPPELSTRÄNGIGEN POLYRIBONUCLEOTIDS UND EINES POLYALKYLENIMINS
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 22/04/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 26/04/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 20/03/2024
- Unitary Effect Registration Date:
- 26/04/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 17/11/2016
- Grant date:
- 20/03/2024
- EP Publication Date:
- 22/04/2020
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 20/03/2024
- EP B1 Publication Date:
- 20/03/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 17/11/2036
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 13/03/2024
- Name:
- Highlight Therapeutics, S.L.
- Address:
- Parque Cientifico de la Universidad de Valencia, C/ Catedrático Agustin Escardino 9, Paterna,, 46980 Valencia, Spain (ES)
Inventor
1
- Name:
- VILLANUEVA GARCÍA, Ana
- Address:
- Spain (ES)
2
- Name:
- QUINTERO ORTIZ, Marisol
- Address:
- Spain (ES)
3
- Name:
- POZUELO RUBIO, Mercedes
- Address:
- Spain (ES)
Priority
- Priority Number:
- 15194864
- Priority Date:
- 17/11/2015
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 9/08; A61K 9/19; A61K 47/26; A61K 31/713; A61K 47/69; A61P 35/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202412
- Publication date:
- 20/03/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202422
- Publication date:
- 29/05/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202422
- Publication date:
- 29/05/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|